Shin Barry

Shin Barry is listed in filings as CFO at Compass Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 4 public disclosures. Recent filings connect the profile to Compass Therapeutics, Inc. (CMPX). The current snapshot covers public activity from Dec 10, 2024 to Jan 5, 2026. Reported amounts are shown as $660.0K to $646.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.